Fargesin promotes LPS-alleviated microglial M2 polarization and relieves neuropathic pain

Neuropathic pain is chronic pain that disrupts a patient’s normal life and causes enormous suffering. Fargesin (Far), a product derived from Mulan, has been discovered to exhibit regulatory functions in multifarious diseases. However, the regulatory impacts and related pathways of Far in neuropathic pain progression remain unclear. In this study, following lipopolysaccharide (LPS) stimulation, cell viability decreased, but was reversed by Far treatment (10, 20 and 40 µM). LPS alleviated M2 polarization, but Far addition offset it. Additionally, Far facilitates gene expressions associated with M2 polarization. Lastly, LPS treatment triggered the nuclear factor kappa-B (NF-κB) pathway, but this change was rescued by Far addition. In conclusion, Far promoted LPS-alleviated microglial M2 polarization and relieved neuropathic pain through retarding the NF-κB pathway. This study may provide novel perspectives on Far in neuropathic pain treatment.

Fargesin; Neuropathic pain; M2 polarization; The NF-κB pathway

[1] Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. The Lancet Neurology. 2010; 9: 807–819.

[2] Inoue K, Tsuda M. Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential. Nature Reviews Neuroscience. 2018; 19: 138–152.

[3] Hooten WM. Chronic pain and mental health disorders: shared neural mechanisms, epidemiology, and treatment. Mayo Clinic Proceedings. 2016; 91: 955–970.

[4] Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: from mechanisms to treatment. Physiological Reviews. 2021; 101: 259–301.

[5] Quintans JSS, Antoniolli AR, Almeida JRGS, Santana‐Filho VJ, Quintans‐Júnior LJ. Natural products evaluated in neuropathic pain models—a systematic review. Basic & Clinical Pharmacology & Toxicology. 2014; 114: 442–450.

[6] Yue B, Ren YJ, Zhang JJ, Luo XP, Yu ZL, Ren GY, et al. Anti-inflammatory effects of fargesin on chemically induced inflammatory bowel disease in mice. Molecules. 2018; 23: 1380.

[7] Lu J, Zhang H, Pan J, Hu Z, Liu L, Liu Y, et al. Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways. Arthritis Research & Therapy. 2021; 23: 142.

[8] Wang G, Gao J, He L, Yu X, Zhao Z, Zou J, et al. Fargesin alleviates atherosclerosis by promoting reverse cholesterol transport and reducing inflammatory response. Molecular and Cell Biology of Lipids. 2020; 1865: 158633.

[9] Wang X, Cheng Y, Xue H, Yue Y, Zhang W, Li X. Fargesin as a potential β₁ adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis. Fitoterapia. 2015; 105: 16–25.

[10] Fu T, Chai B, Shi Y, Dang Y, Ye X. Fargesin inhibits melanin synthesis in murine malignant and immortalized melanocytes by regulating PKA/CREB and P38/MAPK signaling pathways. Journal of Dermatological Science. 2019; 94: 213–219.

[11] Lee GE, Lee CJ, An HJ, Kang HC, Lee HS, Lee JY, et al. Fargesin inhibits EGF-induced cell transformation and colon cancer cell growth by suppression of CDK2/Cyclin E signaling pathway. International Journal of Molecular Sciences. 2021; 22: 2073.

[12] Zhao L, Tao X, Wang Q, Yu X, Dong D. Diosmetin alleviates neuropathic pain by regulating the Keap1/Nrf2/NF-κB signaling pathway. Biomedicine & Pharmacotherapy. 2024; 170: 116067.

[13] Yang L, Zheng W, Lv X, Xin S, Sun Y, Xu T. microRNA-144 modulates the NF-κB pathway in miiuy croaker (Miichthys miiuy) by targeting IκBα gene. Developmental & Comparative Immunology. 2022; 130: 104359.

[14] Nomura Y. NF-kB activation and IkB alpha dynamism involved in iNOS and chemokine induction in astroglial cells. Life Sciences. 2001; 68: 1695–1701.

[15] Lu HJ, Fu YY, Wei QQ, Zhang ZJ. Neuroinflammation in HIV-related neuropathic pain. Frontiers in Pharmacology. 2021; 12: 653852.

[16] Karavis MY, Siafaka I, Vadalouca A, Georgoudis G. Role of microglia in neuropathic pain. Cureus. 2023; 15: e43555.

[17] Bai J, Geng B, Wang X, Wang S, Yi Q, Tang Y, et al. Exercise facilitates the M1-to-M2 polarization of microglia by enhancing autophagy via the BDNF/AKT/mTOR pathway in neuropathic pain. Pain Physician. 2022; 25: E1137–E1151.

[18] Atta AA, Ibrahim WW, Mohamed AF, Abdelkader NF. Microglia polarization in nociplastic pain: mechanisms and perspectives. Inflammopharmacology. 2023; 31: 1053–1067.

[19] Li X, Shi H, Zhang D, Jing B, Chen Z, Zheng Y, et al. Paeonol alleviates neuropathic pain by modulating microglial M1 and M2 polarization via the RhoA/p38MAPK signaling pathway. CNS Neuroscience & Therapeutics. 2023; 29: 2666–2679.

[20] Si W, Li X, Jing B, Chang S, Zheng Y, Chen Z, et al. Stigmasterol regulates microglial M1/M2 polarization via the TLR4/NF-κB pathway to alleviate neuropathic pain. Phytotherapy Research. 2024; 38: 265–279.

[21] Yuan J, Fei Y. Lidocaine ameliorates chronic constriction injury-induced neuropathic pain through regulating M1/M2 microglia polarization. OpenMed. 2022; 17: 897–906.

[22] Shabab T, Khanabdali R, Moghadamtousi SZ, Kadir HA, Mohan G. Neuroinflammation pathways: a general review. International Journal of Neuroscience. 2017; 127: 624–633.

[23] Engelmann C, Weih F, Haenold R. Role of nuclear factor kappa B in central nervous system regeneration. Neural Regeneration Research. 2014; 9: 707–711.

[24] Popiolek-Barczyk K, Mika J. Targeting the microglial signaling pathways: new insights in the modulation of neuropathic pain. Current Medicinal Chemistry. 2016; 23: 2908–2928.

[25] Hu C, He M, Chen M, Xu Q, Li S, Cui Y, et al. Amelioration of neuropathic pain and attenuation of neuroinflammation responses by tetrahydropalmatine through the p38MAPK/NF-κB/iNOS signaling pathways in animal and cellular models. Inflammation. 2022; 45: 891–903.

[26] Huang LN, Zou Y, Wu SG, Zhang HH, Mao QX, Li JB, et al. Fn14 participates in neuropathic pain through NF-κB pathway in primary sensory neurons. Molecular Neurobiology. 2019; 56: 7085–7096.

[27] Zhang Y, Yuan L, Chen Y, Lin C, Ye G. Oxyntomodulin attenuates TNF‑α induced neuropathic pain by inhibiting the activation of the NF‑κB pathway. Molecular Medicine Reports. 2019; 20: 5223–5228.

[28] Pham TH, Kim MS, Le MQ, Song YS, Bak Y, Ryu HW, et al. Fargesin exerts anti-inflammatory effects in THP-1 monocytes by suppressing PKC-dependent AP-1 and NF-κB signaling. Phytomedicine. 2017; 24: 96–103.